| Product | Clinical Indication | Status |
| BC-819 |
Bladder Cancer |
Phase IIb |
| Ovarian Cancer |
Phase I/IIa |
|
Pancreatic Cancer
|
Phase I/IIa |
| Liver Cancer |
Compassionate Use |
| Renal Pelvis TCC |
Compassionate Use |
| BC-820 |
Completed Pre-Clinical Development |
| BC-821 |
Completed Pre-Clinical Development |
| BC-822 (H19-siRNA) |
Completed Pre-Clinical Development |
| Sequential |
Undergoing Pre-Clinical Development |
|